KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 123 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 1.40 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $5,333,000 | +181.3% | 751,101 | +186.4% | 0.36% | +170.5% |
| Q2 2017 | $1,896,000 | +188.6% | 262,301 | +145.8% | 0.13% | +214.3% |
| Q1 2017 | $657,000 | +42.5% | 106,700 | +35.8% | 0.04% | +35.5% |
| Q4 2016 | $461,000 | +159.0% | 78,600 | +133.9% | 0.03% | +244.4% |
| Q3 2016 | $178,000 | -96.9% | 33,600 | -96.2% | 0.01% | -97.1% |
| Q2 2016 | $5,825,000 | +43.3% | 879,900 | +1.1% | 0.31% | +63.4% |
| Q1 2016 | $4,064,000 | -52.7% | 870,200 | -48.9% | 0.19% | -52.5% |
| Q4 2015 | $8,601,000 | +49.7% | 1,703,100 | +4.3% | 0.40% | +61.4% |
| Q3 2015 | $5,746,000 | – | 1,632,300 | – | 0.25% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HUNTINGTON NATIONAL BANK | 1 | $3 | 0.00% |